RUC. Repositorio da Universidade da Coruña
Publicación
Artículo científico (JournalArticle)
Assessment of chromosomal DNA fragmentation by quinolones in an isogenic collection of Escherichia coli with defined resistance mechanisms
[Abstract] The aim of this study was to investigate the potential usefulness of DNA fragmentation as a quick and simple procedure for detecting resistance to fluoroquinolones (FQ) in isogenic Escherichia coli strains harboring defined and multiple quinolone resistance mechanisms, including low-level quinolone resistance (LLQR) phenotypes. DNA fragmentation assay (Micromax(®)) was evaluated for detecting resistance to FQ in 71 isogenic strains of E. coli harboring specific quinolone resistance mechanisms frequently found in clinical isolates. These isogenic strains represent a consistent and reliable model of increasing minimum inhibitory concentrations (MICs) of ciprofloxacin (CIP), ranging from 0.004 to 16 mg/L. According to CLSI criteria, the assay correctly identified all CIP-resistant strains (MIC ≥4 mg/L). As regards susceptible strains, 96% of bacterial strains were correctly assigned as susceptible to CIP. Moreover, the procedure enabled LLQR phenotypes to be efficiently identified; this subset may show different levels of DNA damage depending on the strain, even with similar MIC. Interestingly, despite increasing the dose according to the MIC, a lower response to quinolones occurs in strains with higher MIC values. This is a simple, rapid, and reliable test for evaluating susceptibility to FQ of E. coli, including the detection of strains harboring LLQR mechanisms., This work was supported by the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (projects PI11-00934, PI14/00940, and PI14/01346), and the Consejerı´a de Innovacio´n Ciencia y Empresa, Junta de Andalucı´a (P11-CTS7730), Spain; also by the Plan Nacional de I+D+i 2008–2011 and the Instituto de Salud Carlos III, Subdireccio´n General de Redes y Centros de Investigacio´n Cooperativa, Ministerio de Economı´a y Competitividad, and the Spanish Network for Research in Infectious Diseases (REIPI RD12/0015)— cofinanced by the European Development Regional Fund ‘‘A way to achieve Europe’’ ERDF.
Proyecto:
MINECO PI14-00940
,
MINECO PI14-01346